Daily Stock Ratings & Price Targets

Daily stock ratings from over 8,000 Wall Street analysts

Daily Buy Ratings

Analyst & Firm	Company	Rating & Price Target	Upside / Downside
Stephen Brozak WBB Securities	OMER Omeros	BUY$45	192.97% Upside
David Katz Jefferies	RRR Red Rock Resorts	BUY$73	17.65% Upside
Joseph Pantginis H.C. Wainwright	EWTX Edgewise Therapeutics	BUY$42	53.90% Upside
Jason Kolbert D. Boral Capital	OMER Omeros	BUY$36	134.38% Upside

Daily Sell Ratings

Analyst & Firm	Company	Rating & Price Target	Upside / Downside
Ross Fowler Bank of America Securities	AVA Avista	SELL$36	-6.18% Downside
John Barnidge Piper Sandler	AMP Ameriprise Financial	SELL$434	-13.37% Downside
Steven Cahall Wells Fargo	CMCSA Comcast	SELL$29	-2.62% Downside
Joshua Spector UBS	LYB LyondellBasell	SELL$38	-11.36% Downside

Full List of Stock Ratings

(Dec 24, 2025)

Analyst Performance

Any

Analyst Rating

Any

Upside / Downside

Any

Action

Any

Market Cap

Any

Analyst & Firm	Company	Rating & Price Target	Upside / Downside	Average Return	Action	Date	Article
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $22	―	25.20%	Assigned	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $1.5	―	11.30%	Reiterated	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD	―	6.10%	Downgraded	2025-12-24
James McIlree Chardan Capital	HYPD Hyperion DeFi	BUY $7.75	―	-29.10%	Initiated	2025-12-24	Hyperion DeFi (HYPD) Gets a Buy from Chardan Capital
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $218	―	16.10%	Reiterated	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $269→$250	―	12.70%	Reiterated	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $245	―	12.30%	Reiterated	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $250.6	―	6.90%	Reiterated	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $115→$113	―	14.00%	Reiterated	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $32→$34	―	4.20%	Reiterated	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $73	―	41.60%	Assigned	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $8.5	―	9.60%	Reiterated	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $15	―	16.80%	Reiterated	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $93→$103	―	18.70%	Reiterated	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $16	―	5.10%	Reiterated	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $280	―	16.80%	Reiterated	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY	―	23.30%	Reiterated	2025-12-24
Karina Rabayeva Truist Financial	JANX Janux Therapeutics Inc	BUY	―	-25.70%	Reiterated	2025-12-24	Analysts Offer Insights on Healthcare Companies: MannKind (NASDAQ: MNKD) and Janux Therapeutics Inc (NASDAQ: JANX)
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $35	―	20.00%	Reiterated	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY	―	20.00%	Reiterated	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $240	―	15.20%	Reiterated	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $151→$148	―	13.50%	Reiterated	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $1,100	―	15.30%	Upgraded	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $25	―	15.20%	Reiterated	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $0.97	―	20.90%	Reiterated	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $31	―	3.20%	Reiterated	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $475	―	16.10%	Reiterated	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $180→$215	―	1.60%	Reiterated	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $62→$65	―	9.10%	Reiterated	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $52→$53	―	9.10%	Reiterated	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $75	―	9.10%	Reiterated	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $48	―	9.10%	Reiterated	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $280	―	0.50%	Reiterated	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD	―	4.80%	Downgraded	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $263→$308	―	25.60%	Reiterated	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $21→$25	―	25.60%	Reiterated	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $10→$7	―	6.90%	Reiterated	2025-12-24
Anthony Vendetti Maxim Group	YCBD cbdMD	BUY $2	―	-24.30%	Reiterated	2025-12-24	Maxim Group Keeps Their Buy Rating on cbdMD (YCBD)
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $23	―	4.10%	Reiterated	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $55	―	16.20%	Reiterated	2025-12-24
Elizabeth Anderson CFA Evercore ISI	HSIC Henry Schein	BUY $90	―	-2.20%	Reiterated	2025-12-24	Evercore ISI Reaffirms Their Buy Rating on Henry Schein (HSIC)
Steve Sakwa Evercore ISI	BXP BXP	HOLD $76	―	0.00%	Reiterated	2025-12-24	Evercore ISI Remains a Hold on BXP (BXP)
Michael Donovan Compass Point	CIFR Cipher Mining	BUY $28	―	-10.70%	Reiterated	2025-12-24	Cipher Mining (CIFR) Gets a Buy from Compass Point
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $26	―	23.00%	Reiterated	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $13	―	23.00%	Reiterated	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $33	―	7.50%	Reiterated	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $46	―	18.70%	Reiterated	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $14	―	0.70%	Reiterated	2025-12-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $0.25	―	0.70%	Reiterated	2025-12-24
Mark Reichman Noble Financial	LODE Comstock Mining	HOLD	―	-8.40%	Downgraded	2025-12-24	Noble Financial downgrades Comstock Mining (LODE) to a Hold

Rows:

Ready for the Full Picture?Your current plan limits your access to top-tier analyst ratings. Subscribe to Premium now and unlock the full range of ratings from the highest-ranked analysts on Wall Street. Don't let partial views limit your market research potential - upgrade today!

Upgrade Now Plans & Pricing